Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis

Maspin is a mammary serine protease inhibitor or serpin with tumor suppressive and antiangiogenic activity that inhibits tumor motility, invasion and metastasis, at least by its actions on cell membrane and extracellular matrix (ECM) proteins. Previous studies documented that the quinazoline-derived α1-adrenoceptor antagonist doxazosin affects the attachment and migration of prostate cancer cells. In this study, we investigated the effect of maspin overexpression on the apoptotic/antiadhesion response of prostate cancer cells to doxazosin. The response of maspin-overexpressing clones of human prostate cancer cells DU-145 to doxazosin was evaluated by determining cell viability, apoptosis and cell proliferation on the basis of the trypan blue exclusion assay/methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay, Hoechst staining and caspase-3 activation, and [3H]thymidine incorporation assay. Vascular endothelial growth factor (VEGF), transforming growth factor βRII (TGFβRII), Smad4 (a TGFβ intracellular effector) and bax expression was evaluated at the mRNA and protein level using reverse transcriptase–polymerase chain reaction and Western blotting, respectively. The effect of doxazosin on cell attachment of maspin-expressing prostate cancer cells was evaluated on collagen- and fibronectin-coated plates. Cell migration was assessed using the wounding assay. In response to tumor necrosis factor-related apoptosis-inducing ligand, DU-145-maspin expressing cells undergo apoptosis, via poly(ADP-ribose) polymerasecleavage and caspase-3 activation. DU-145-maspin cells exhibited higher sensitivity to doxazosin and an earlier temporal activation of caspase-3. The number of apoptotic cells detected in response to doxazosin was significantly higher compared to the neo control (P<0.0001). Doxazosin resulted in dramatic downregulation of the 189 isoform of VEGF in maspin transfectants, while a fivefold induction of Smad4 mRNA expression was detected in those cells after 24 h of treatment. Maspin overexpression in prostate cancer cells resulted in an increased ability to attach to ECM-coated plates, and doxazosin treatment considerably antagonized this effect by decreasing the attachment potential to collagen and fibronectin. The present study supports the ability of maspin to enhance the apoptotic threshold of prostate cancer cells to the quinazoline-based α1-adrenoceptor antagonist doxazosin. These findings may have therapeutic significance in the development of antiangiogenic targeting by doxazosin and derivative agents for advanced prostate cancer.

[1]  N. Kyprianou,et al.  Quinazoline-based α1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-β signalling and IκBα induction , 2003, British Journal of Cancer.

[2]  S. Sheng,et al.  Maspin sensitizes breast carcinoma cells to induced apoptosis , 2002, Oncogene.

[3]  M. Hendrix,et al.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  N. Kyprianou,et al.  Reduction of human prostate tumor vascularity by the α1‐adrenoceptor antagonist terazosin , 2001 .

[5]  G. Oades,et al.  The clinical role of α-blockers in the treatment of benign prostatic hyperplasia , 2000 .

[6]  N. Kyprianou,et al.  Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2. , 2003, The Journal of urology.

[7]  G. Yang,et al.  Transforming growth factor β1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosin , 1997, The Prostate.

[8]  M. Hendrix,et al.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.

[9]  A. Shabsigh,et al.  Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans. , 1999, Biology of reproduction.

[10]  N. Greenberg,et al.  Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. , 2003, The Journal of urology.

[11]  O. Blacque,et al.  Evidence for a Direct Interaction between the Tumor Suppressor Serpin, Maspin, and Types I and III Collagen* , 2002, The Journal of Biological Chemistry.

[12]  S. Sheng,et al.  Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Luzhe Sun,et al.  Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*) , 1995, The Journal of Biological Chemistry.

[14]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[15]  J. B. Garrison,et al.  Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion , 2005, Journal of cellular biochemistry.